Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Obinutuzumab

EU orphan designation number: EU/3/14/1325   
Active ingredient: Obinutuzumab
Indication: Treatment of diffuse large B-cell lymphoma
Sponsor: Roche Registration Limited
6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/08/2014 Orphan designation EMA/OD/092/14 (2014)6130 of 22/08/2014